American Portfolios Advisors’s Akoustis Technologies Inc AKTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$154 Hold
52
﹤0.01% 3470
2022
Q2
$192 Hold
52
﹤0.01% 3465
2022
Q1
$338 Sell
52
-1,925
-97% -$11.5K ﹤0.01% 3503
2021
Q4
$13.2K Buy
1,977
+625
+46% +$4.67K ﹤0.01% 2516
2021
Q3
$13.1K Buy
1,352
+900
+199% +$8.63K ﹤0.01% 2459
2021
Q2
$4.84K Hold
452
﹤0.01% 2827
2021
Q1
$6.03K Hold
452
﹤0.01% 2627
2020
Q4
$5.53K Hold
452
﹤0.01% 2368
2020
Q3
$3.69K Hold
452
﹤0.01% 2393
2020
Q2
$3.75K Buy
452
+300
+197% +$2.32K ﹤0.01% 2338
2020
Q1
$816 Hold
152
﹤0.01% 2592
2019
Q4
$1.22K Hold
152
﹤0.01% 2666
2019
Q3
$1.18K Buy
152
+52
+52% +$342 ﹤0.01% 2617
2019
Q2
$640 Hold
100
﹤0.01% 2627
2019
Q1
$581 Hold
100
﹤0.01% 2520
2018
Q4
$497 Buy
+100
New +$514 ﹤0.01% 2311

Other funds holding AKTS

American Portfolios Advisors's AKTS Position: Q3 2022 in Review

American Portfolios Advisors held its Akoustis Technologies Inc (AKTS) position steady in Q3 2022 at 52 shares worth $154. The position accounts for ﹤0.01% of the portfolio, ranked #3470.

American Portfolios Advisors first reported a position in AKTS in Q4 2018 and has held it in 16 quarters since. The position peaked at $13.2K in Q4 2021. 126 funds tracked by Wall St. Rank hold AKTS as of Q3 2022.

  • American Portfolios Advisors held 52 shares of Akoustis Technologies Inc worth $154 as of Q3 2022.
  • American Portfolios Advisors left its Akoustis Technologies Inc share count unchanged in Q3 2022.
  • Akoustis Technologies Inc made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #3470 holding.
  • American Portfolios Advisors first reported a position in Akoustis Technologies Inc in Q4 2018 and has held it in 16 quarters since.
  • American Portfolios Advisors's Akoustis Technologies Inc position peaked at $13.2K in Q4 2021.
  • 126 funds tracked by Wall St. Rank held Akoustis Technologies Inc as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.